gatifloxacin has been researched along with Diabetes Mellitus in 5 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the current study was to identify risk factors for hyperglycemia in hospitalized patients receiving gatifloxacin." | 7.74 | Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis. ( Lodise, TP; Mohr, JF; Ostrosky-Zeichner, L; Peymann, PJ; Troxell, E, 2008) |
| "A retrospective cohort study of hospitalized adult (> or =18 years) patients admitted with Community Acquired Pneumonia (CAP) or Acute Exacerbation of Chronic Bronchitis (AECB) in a US tertiary care hospital between 7/1/01 and 12/31/04 treated with gatifloxacin or ceftriaxone during hospital admission." | 3.74 | An evaluation of the effects of gatifloxacin on glucose homeostasis. ( Hatton, RC; Onyenwenyi, AJ; Winterstein, AG, 2008) |
| "The purpose of the current study was to identify risk factors for hyperglycemia in hospitalized patients receiving gatifloxacin." | 3.74 | Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis. ( Lodise, TP; Mohr, JF; Ostrosky-Zeichner, L; Peymann, PJ; Troxell, E, 2008) |
| "Gatifloxacin, a commonly prescribed antimicrobial can produce profound hypoglycemia and disturbances in glucose homeostasis especially in diabetes patients on sulphonylureas." | 3.73 | Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride. ( Kesavadev, J; Rasheed, SA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bushardt, RL | 1 |
| Kendall, C | 1 |
| Wooltorton, E | 1 |
| Kesavadev, J | 1 |
| Rasheed, SA | 1 |
| Onyenwenyi, AJ | 1 |
| Winterstein, AG | 1 |
| Hatton, RC | 1 |
| Mohr, JF | 1 |
| Peymann, PJ | 1 |
| Troxell, E | 1 |
| Lodise, TP | 1 |
| Ostrosky-Zeichner, L | 1 |
5 other studies available for gatifloxacin and Diabetes Mellitus
| Article | Year |
|---|---|
Fluctuating blood glucose levels in an elderly diabetic patient.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Interactions; Fluoroq | 2006 |
People with diabetes should avoid antibiotic gatifloxacin.
Topics: Bacterial Infections; Case-Control Studies; Contraindications; Diabetes Mellitus; Fluoroquinolones; | 2006 |
Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
Topics: Anti-Infective Agents; Blood Glucose; Diabetes Mellitus; Female; Fluoroquinolones; Gatifloxacin; Hom | 2006 |
An evaluation of the effects of gatifloxacin on glucose homeostasis.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Bronchitis; Ceftriaxone; Cohort Studies; Communit | 2008 |
Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis.
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Case-Control Studies; Diabetes Mellitus; Dose- | 2008 |